Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS for IFP Estimation in Breast Cancer
NCT04721886Phase 1Completed
- Sponsor
- Thomas Jefferson University
- Start
- Nov 2020
- Primary completion
- Jul 2023
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of perflutren lipid microspheres in breast cancer, sponsored by Thomas Jefferson University. Primary endpoint: Correlation Between Subharmonic Aided Pressure Estimation (SHAPE) Results and Direct Measurements of Interstitial Fluid Pressure (IFP) at 90 minutes. Started Nov 2020; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04721886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04721886.